Previous studies have provided evidence that although anti-IFN-α and/or IFN-ω autoantibodies are commonly observed, the presence of anti-IFN-β autoantibodies in patients with COVID-19 is infrequently reported [16]. Here, IFNA1 is linked to COVID-19.